1567360-66-0

Basic information

• Product Name: 5-((2,3-dichloro-4-(4-(4-((2-oxo-1,2,3,4-tetrahydroquinolin-7-yl)oxy)butyl)piperazin-1-yl)phenyl)amino)-5-oxopentanoic acid
• Synonyms: 5-((2,3-dichloro-4-(4-(4-((2-oxo-1,2,3,4-tetrahydroquinolin-7-yl)oxy)butyl)piperazin-1-yl)phenyl)amino)-5-oxopentanoic acid
• CAS NO: 1567360-66-0
• Molecular Weight: 577.508
• Mol File: 1567360-66-0.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: 5-((2,3-dichloro-4-(4-(4-((2-oxo-1,2,3,4-tetrahydroquinolin-7-yl)oxy)butyl)piperazin-1-yl)phenyl)amino)-5-oxopentanoic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 5-((2,3-dichloro-4-(4-(4-((2-oxo-1,2,3,4-tetrahydroquinolin-7-yl)oxy)butyl)piperazin-1-yl)phenyl)amino)-5-oxopentanoic acid(1567360-66-0)
• EPA Substance Registry System: 5-((2,3-dichloro-4-(4-(4-((2-oxo-1,2,3,4-tetrahydroquinolin-7-yl)oxy)butyl)piperazin-1-yl)phenyl)amino)-5-oxopentanoic acid(1567360-66-0)

Safety Data

• Hazardous Substances Data: 1567360-66-0(Hazardous Substances Data)

Upstream product

• 56978-48-4 4-bromo-2,3-dichloro-phenylamine 
• 1567360-63-7 4-bromo-2,3-dichloro-N-(4-methoxybenzyl)aniline 
• 1567360-62-6 2,3-dichloro-N-(4-methoxybenzyl)-4-(piperazin-1-yl)aniline 
• 1567360-64-8 2,3-dichloro-4-(piperazin-1-yl)aniline 
• 129722-34-5 7-(4-bromobutoxy)-3,4-dihydro-2(1H)-quinolinone 
• 1567360-61-5 7-(4-(4-(4-amino-2,3-dichlorophenyl)piperazin-1-yl)butoxy)-3,4-dihydroquinolin-2(1H)-one 
• 53715-97-2 5,5'-oxybis(5-oxopentanoic acid) 
• 108-55-4 glutaric anhydride, 

Relevant articles and documents

Antibodies to aripiprazole haptens and use thereof

Disclosed is an antibody which binds to aripiprazole, which can be used to detect aripiprazole in a sample such as in a competitive immunoassay method. The antibody can be used in a lateral flow assay device for point-of-care detection of aripiprazole, in

HAPTENS OF ARIPIPRAZOLE AND THEIR USE IN IMMUNOASSAYS

The invention relates to compounds of Formula I, wherein R1, R2, and R3 are defined in the specification, useful for the synthesis of novel conjugates and immunogens derived from aripiprazole. The invention also relates to